[1] V. Aleksic et al., "Ligamentum flavum analysis in patients with lumbar discus hernia and lumbar spinal stenosis," Sci Rep, vol. 13, no. 1, p. 3804, Mar 7 2023, doi: 10.1038/s41598-023-30928-x.
[2] K. Sairyo et al., "Pathomechanism of Ligamentum Flavum Hypertrophy: A Multidisciplinary Investigation Based on Clinical, Biomechanical, Histologic, and Biologic Assessments," Spine, vol. 30, no. 23, pp. 2649-2656, 2005, doi: 10.1097/01.brs.0000188117.77657.ee.
[3] A. A. Safak et al., "The thickness of the ligamentum flavum in relation to age and gender," Clin Anat, vol. 23, no. 1, pp. 79-83, Jan 2010, doi: 10.1002/ca.20883.
[4] T. Saito et al., "Macrophage Infiltration Is a Causative Factor for Ligamentum Flavum Hypertrophy through the Activation of Collagen Production in Fibroblasts," Am J Pathol, vol. 187, no. 12, pp. 2831-2840, Dec 2017, doi: 10.1016/j.ajpath.2017.08.020.
[5] D. Hulmani, B. Garg, N. Mehta, A. R. Mridha, T. C. Nag, and K. Farooque, "Morphological Changes in the Ligamentum Flavum in Degenerative Lumbar Canal Stenosis: A Prospective, Comparative Study," Asian Spine J, vol. 14, no. 6, pp. 773-781, Dec 2020, doi: 10.31616/asj.2020.0041.
[6] K. Ono, K. Yonenobu, S. Miyamoto, and K. Okada, "Pathology of Ossification of the Posterior Longitudinal Ligament and Ligamentum Flavum," Clinical Orthopaedics and Related Research®, vol. 359, pp. 18-26, 1999. [Online]. Available: https://journals.lww.com/clinorthop/fulltext/1999/02000/pathology_of_ossification_of_the_posterior.3.aspx.
[7] C. Sun, H. Zhang, X. Wang, and X. Liu, "Ligamentum flavum fibrosis and hypertrophy: Molecular pathways, cellular mechanisms, and future directions," FASEB J, vol. 34, no. 8, pp. 9854-9868, Aug 2020, doi: 10.1096/fj.202000635R.
[8] M. L. George et al., "VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression," Neoplasia, vol. 3, no. 5, pp. 420-7, Sep-Oct 2001, doi: 10.1038/sj.neo.7900186.
[9] N. Ferrara, "Vascular endothelial growth factor: basic science and clinical progress," Endocr Rev, vol. 25, no. 4, pp. 581-611, Aug 2004, doi: 10.1210/er.2003-0027.
[10] J.-B. Park, H. Chang, and J.-K. Lee, "Quantitative Analysis of Transforming Growth Factor-Beta 1 in Ligamentum Flavum of Lumbar Spinal Stenosis and Disc Herniation," Spine, vol. 26, no. 21, pp. E492-E495, 2001. [Online]. Available: https://journals.lww.com/spinejournal/fulltext/2001/11010/quantitative_analysis_of_transforming_growth.7.aspx.
[11] H. Kosaka et al., "Pathomechanism of Loss of Elasticity and Hypertrophy of Lumbar Ligamentum Flavum in Elderly Patients With Lumbar Spinal Canal Stenosis," Spine, vol. 32, no. 25, pp. 2805-2811, 2007, doi: 10.1097/BRS.0b013e31815b650f.
[12] J. W. Hur et al., "The Mechanism of Ligamentum Flavum Hypertrophy: Introducing Angiogenesis as a Critical Link That Couples Mechanical Stress and Hypertrophy," Neurosurgery, vol. 77, no. 2, pp. 274-81; discussion 281-2, Aug 2015, doi: 10.1227/NEU.0000000000000755.
[13] S. Lakemeier et al., "Expression of Hypoxia-inducible Factor-1α, Vascular Endothelial Growth Factor, and Matrix Metalloproteinases 1, 3, and 9 in Hypertrophied Ligamentum Flavum," Clinical Spine Surgery, vol. 26, no. 7, pp. 400-406, 2013, doi: 10.1097/BSD.0b013e3182495b88.
[14] D. E. Ingber, "Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology," Circ Res, vol. 91, no. 10, pp. 877-87, Nov 15 2002, doi: 10.1161/01.res.0000039537.73816.e5.
[15] A. L. Sieminski, R. P. Hebbel, and K. J. Gooch, "The relative magnitudes of endothelial force generation and matrix stiffness modulate capillary morphogenesis in vitro," Exp Cell Res, vol. 297, no. 2, pp. 574-84, Jul 15 2004, doi: 10.1016/j.yexcr.2004.03.035.
[16] P. K. Schräder, D. Grob, B. A. Rahn, J. Cordey, and J. Dvorak, "Histology of the ligamentum flavum in patients with degenerative lumbar spinal stenosis," European Spine Journal, vol. 8, no. 4, pp. 323-328, 1999.
[17] M. Yoshida, K. Shima, Y. Taniguchi, T. Tamaki, and T. Tanaka, "Hypertrophied ligamentum flavum in lumbar spinal canal stenosis: pathogenesis and morphologic and immunohistochemical observation," Spine, vol. 17, no. 11, pp. 1353-1360, 1992.
[18] Y. Kokubo et al., "Herniated and spondylotic intervertebral discs of the human cervical spine: histological and immunohistochemical observations," Acta Histochemica et Cytochemica, vol. 37, no. 2, pp. 109-117, 2004.
[19] N. Ferrara, "Vascular endothelial growth factor: basic science and clinical progress," Endocrine reviews, vol. 25, no. 4, pp. 581-611, 2004.
[20] P. R. Lawler and J. Lawler, "Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2," Cold Spring Harb Perspect Med, vol. 2, no. 5, p. a006627, May 2012, doi: 10.1101/cshperspect.a006627.
[21] P. J. Newman, "The biology of PECAM-1," The Journal of clinical investigation, vol. 99, no. 1, pp. 3-8, 1997.
[22] T. Yoshiiwa, M. Miyazaki, N. Notani, T. Ishihara, M. Kawano, and H. Tsumura, "Analysis of the Relationship between Ligamentum Flavum Thickening and Lumbar Segmental Instability, Disc Degeneration, and Facet Joint Osteoarthritis in Lumbar Spinal Stenosis," Asian Spine J, vol. 10, no. 6, pp. 1132-1140, Dec 2016, doi: 10.4184/asj.2016.10.6.1132.
[23] W. K. Kwon, H. J. Moon, T. H. Kwon, Y. K. Park, and J. H. Kim, "The Role of Hypoxia in Angiogenesis and Extracellular Matrix Regulation of Intervertebral Disc Cells During Inflammatory Reactions," Neurosurgery, vol. 81, no. 5, pp. 867-875, Nov 1 2017, doi: 10.1093/neuros/nyx149.
[24] R. Rezakhaniha et al., "Experimental investigation of collagen waviness and orientation in the arterial adventitia using confocal laser scanning microscopy," Biomech Model Mechanobiol, vol. 11, no. 3-4, pp. 461-73, Mar 2012, doi: 10.1007/s10237-011-0325-z.
[25] J. W. Hur et al., "Myofibroblast in the ligamentum flavum hypertrophic activity," Eur Spine J, vol. 26, no. 8, pp. 2021-2030, Aug 2017, doi: 10.1007/s00586-017-4981-2.
[26] I. Altun and K. Z. Yuksel, "Histopathological Analysis of Ligamentum Flavum in Lumbar Spinal Stenosis and Disc Herniation," Asian Spine J, vol. 11, no. 1, pp. 71-74, Feb 2017, doi: 10.4184/asj.2017.11.1.71.
[27] S. Fukuyama, T. Nakamura, T. Ikeda, and K. Takagi, "The Effect of Mechanical Stress on Hypertrophy of the Lumbar Ligamentum Flavum," Clinical Spine Surgery, vol. 8, no. 2, pp. 126-130, 1995. [Online]. Available: https://journals.lww.com/jspinaldisorders/fulltext/1995/04000/the_effect_of_mechanical_stress_on_hypertrophy_of.6.aspx.
[28] P. Bornstein, "Thrombospondins function as regulators of angiogenesis," J Cell Commun Signal, vol. 3, no. 3-4, pp. 189-200, Dec 2009, doi: 10.1007/s12079-009-0060-8.
[29] Y. L. Cao, Y. Duan, L. X. Zhu, Y. N. Zhan, S. X. Min, and A. M. Jin, "TGF-beta1, in association with the increased expression of connective tissue growth factor, induce the hypertrophy of the ligamentum flavum through the p38 MAPK pathway," Int J Mol Med, vol. 38, no. 2, pp. 391-8, Aug 2016, doi: 10.3892/ijmm.2016.2631.
[30] T. A. Wynn, "Cellular and molecular mechanisms of fibrosis," J Pathol, vol. 214, no. 2, pp. 199-210, Jan 2008, doi: 10.1002/path.2277.
[31] J.-B. Park, K.-W. Kim, C.-W. Han, and H. Chang, "Expression of Fas Receptor on Disc Cells in Herniated Lumbar Disc Tissue," Spine, vol. 26, no. 2, pp. 142-146, 2001. [Online]. Available: https://journals.lww.com/spinejournal/fulltext/2001/01150/expression_of_fas_receptor_on_disc_cells_in.6.aspx.
[32] M. Imamori et al., "Thrombospondin-1 promotes liver fibrosis by enhancing TGF-beta action in hepatic stellate cells," Biochem Biophys Res Commun, vol. 693, p. 149369, Jan 22 2024, doi: 10.1016/j.bbrc.2023.149369.
[33] J. E. Murphy-Ullrich and M. Poczatek, "Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology," (in eng), Cytokine Growth Factor Rev, vol. 11, no. 1-2, pp. 59-69, Mar-Jun 2000, doi: 10.1016/s1359-6101(99)00029-5.
[34] J. C. Adams and J. Lawler, "The thrombospondins," (in eng), Cold Spring Harb Perspect Biol, vol. 3, no. 10, p. a009712, Oct 1 2011, doi: 10.1101/cshperspect.a009712.
[35] S. Kaur and D. D. Roberts, "Emerging functions of thrombospondin-1 in immunity," Semin Cell Dev Biol, vol. 155, no. Pt B, pp. 22-31, Mar 1 2024, doi: 10.1016/j.semcdb.2023.05.008.
[36] T. R. Kyriakides and S. Maclauchlan, "The role of thrombospondins in wound healing, ischemia, and the foreign body reaction," J Cell Commun Signal, vol. 3, no. 3-4, pp. 215-25, Dec 2009, doi: 10.1007/s12079-009-0077-z.
[37] H. Hayashi, K. Sakai, H. Baba, and T. Sakai, "Thrombospondin-1 is a novel negative regulator of liver regeneration after partial hepatectomy through transforming growth factor-beta1 activation in mice," Hepatology, vol. 55, no. 5, pp. 1562-73, May 2012, doi: 10.1002/hep.24800.
[38] J. E. Murphy-Ullrich and E. H. Sage, "Revisiting the matricellular concept," Matrix Biol, vol. 37, pp. 1-14, Jul 2014, doi: 10.1016/j.matbio.2014.07.005.
[39] S. Kaur, G. Martin-Manso, M. L. Pendrak, S. H. Garfield, J. S. Isenberg, and D. D. Roberts, "Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47," J Biol Chem, vol. 285, no. 50, pp. 38923-32, Dec 10 2010, doi: 10.1074/jbc.M110.172304.
[40] G.-B. Jeong, "Thrombospondin-1 and Inhibition of Tumor Growth," Korean Journal of Physical Anthropology, vol. 28, no. 4, 2015, doi: 10.11637/kjpa.2015.28.4.175.